Literature DB >> 20815112

The real cost of counterfeit medicines.

Talha Burki.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20815112     DOI： 10.1016/s1473-3099(10)70173-0

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  3 in total

1.  Health policy and systems research in access to medicines: a prioritized agenda for low- and middle-income countries.

Authors:  Maryam Bigdeli; Dena Javadi; Joelle Hoebert; Richard Laing; Kent Ranson
Journal:  Health Res Policy Syst       Date:  2013-10-14

2.  Pervasive antibiotic misuse in the Cambodian community: antibiotic-seeking behaviour with unrestricted access.

Authors:  Chhorvoin Om; Frances Daily; Erika Vlieghe; James C McLaughlin; Mary-Louise McLaws
Journal:  Antimicrob Resist Infect Control       Date:  2017-03-24       Impact factor: 4.887

Review 3.  Access to medicines from a health system perspective.

Authors:  Maryam Bigdeli; Bart Jacobs; Goran Tomson; Richard Laing; Abdul Ghaffar; Bruno Dujardin; Wim Van Damme
Journal:  Health Policy Plan       Date:  2012-11-22       Impact factor: 3.344
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.